Skip to main content
NCBI home page
Gut logoLink to Gut
. 1992 May;33(5):576–579. doi: 10.1136/gut.33.5.576

Strategies for hepatitis B immunisation.

A P Catterall 1, I M Murray-Lyon 1
PMCID: PMC1379280  PMID: 1612471

Full text

PDF
576

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alper C. A., Kruskall M. S., Marcus-Bagley D., Craven D. E., Katz A. J., Brink S. J., Dienstag J. L., Awdeh Z., Yunis E. J. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med. 1989 Sep 14;321(11):708–712. doi: 10.1056/NEJM198909143211103. [DOI] [PubMed] [Google Scholar]
  2. Alter M. J., Ahtone J., Weisfuse I., Starko K., Vacalis T. D., Maynard J. E. Hepatitis B virus transmission between heterosexuals. JAMA. 1986 Sep 12;256(10):1307–1310. [PubMed] [Google Scholar]
  3. Alter M. J., Coleman P. J., Alexander W. J., Kramer E., Miller J. K., Mandel E., Hadler S. C., Margolis H. S. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA. 1989 Sep 1;262(9):1201–1205. [PubMed] [Google Scholar]
  4. Alter M. J., Hadler S. C., Margolis H. S., Alexander W. J., Hu P. Y., Judson F. N., Mares A., Miller J. K., Moyer L. A. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA. 1990 Mar 2;263(9):1218–1222. [PubMed] [Google Scholar]
  5. Baddick M. R., Aw T. C. Immunisation against hepatitis B among NHS staff in West Midlands Regional Health Authority. BMJ. 1989 Sep 2;299(6699):607–607. doi: 10.1136/bmj.299.6699.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Barin F., Perrin J., Chotard J., Denis F., N'Doye R., Diop Mar I., Chiron J. P., Coursaget P., Goudeau A., Maupas P. Cross-sectional and longitudinal epidemiology of hepatitis B in Senegal. Prog Med Virol. 1981;27:148–162. [PubMed] [Google Scholar]
  7. Beasley R. P., Hwang L. Y. Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis. 1984 May;4(2):113–121. doi: 10.1055/s-2008-1040651. [DOI] [PubMed] [Google Scholar]
  8. Beasley R. P., Hwang L. Y., Lee G. C., Lan C. C., Roan C. H., Huang F. Y., Chen C. L. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983 Nov 12;2(8359):1099–1102. doi: 10.1016/s0140-6736(83)90624-4. [DOI] [PubMed] [Google Scholar]
  9. Brook M. G., Lever A. M., Kelly D., Rutter D., Trompeter R. S., Griffiths P., Thomas H. C. Antenatal screening for hepatitis B is medically and economically effective in the prevention of vertical transmission: three years experience in a London hospital. Q J Med. 1989 Apr;71(264):313–317. [PubMed] [Google Scholar]
  10. Carman W. F., Zanetti A. R., Karayiannis P., Waters J., Manzillo G., Tanzi E., Zuckerman A. J., Thomas H. C. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 1990 Aug 11;336(8711):325–329. doi: 10.1016/0140-6736(90)91874-a. [DOI] [PubMed] [Google Scholar]
  11. Chen D. S., Hsu N. H., Sung J. L., Hsu T. C., Hsu S. T., Kuo Y. T., Lo K. J., Shih Y. T. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA. 1987 May 15;257(19):2597–2603. [PubMed] [Google Scholar]
  12. Collier A. C., Corey L., Murphy V. L., Handsfield H. H. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med. 1988 Jul 15;109(2):101–105. doi: 10.7326/0003-4819-109-2-101. [DOI] [PubMed] [Google Scholar]
  13. Coursaget P., Yvonnet B., Gilks W. R., Wang C. C., Day N. E., Chiron J. P., Diop-Mar I. Scheduling of revaccination against hepatitis B virus. Lancet. 1991 May 18;337(8751):1180–1183. doi: 10.1016/0140-6736(91)92857-x. [DOI] [PubMed] [Google Scholar]
  14. Coursaget P., Yvonnet B., Relyveld E. H., Barres J. L., Diop-Mar I., Chiron J. P. Simultaneous administration of diphtheria-tetanus-pertussis-polio and hepatitis B vaccines in a simplified immunization program: immune response to diphtheria toxoid, tetanus toxoid, pertussis, and hepatitis B surface antigen. Infect Immun. 1986 Mar;51(3):784–787. doi: 10.1128/iai.51.3.784-787.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Davis L. G., Weber D. J., Lemon S. M. Horizontal transmission of hepatitis B virus. Lancet. 1989 Apr 22;1(8643):889–893. doi: 10.1016/s0140-6736(89)92876-6. [DOI] [PubMed] [Google Scholar]
  16. Degos F., Duhamel G., Brechot C., Nalpas B., Courouce A. M., Tron F., Berthelot P. Hepatitis B vaccination in chronic alcoholics. J Hepatol. 1986;2(3):402–409. doi: 10.1016/s0168-8278(86)80051-4. [DOI] [PubMed] [Google Scholar]
  17. Denis F., Mounier M., Hessel L., Michel J. P., Gualde N., Dubois F., Barin F., Goudeau A. Hepatitis-B vaccination in the elderly. J Infect Dis. 1984 Jun;149(6):1019–1019. doi: 10.1093/infdis/149.6.1019. [DOI] [PubMed] [Google Scholar]
  18. Ferrari C., Penna A., Bertoletti A., Cavalli A., Valli A., Schianchi C., Fiaccadori F. The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man. J Clin Invest. 1989 Oct;84(4):1314–1319. doi: 10.1172/JCI114299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ghaffar Y. A., Kamel M., el-Sobky M., Bahnasy R., Strickland G. T. Response to hepatitis B vaccine in infants born to mothers with schistosomiasis. Lancet. 1989 Jul 29;2(8657):272–272. doi: 10.1016/s0140-6736(89)90453-4. [DOI] [PubMed] [Google Scholar]
  20. Hadler S. C., Francis D. P., Maynard J. E., Thompson S. E., Judson F. N., Echenberg D. F., Ostrow D. G., O'Malley P. M., Penley K. A., Altman N. L. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med. 1986 Jul 24;315(4):209–214. doi: 10.1056/NEJM198607243150401. [DOI] [PubMed] [Google Scholar]
  21. Heijtink R. A., Knol R. M., Schalm S. W. Low-dose (2 micrograms) hepatitis B vaccination in medical students: comparable immunogenicity for intramuscular and intradermal routes. J Med Virol. 1989 Feb;27(2):151–154. doi: 10.1002/jmv.1890270216. [DOI] [PubMed] [Google Scholar]
  22. Hoofnagle J. H. Toward universal vaccination against hepatitis B virus. N Engl J Med. 1989 Nov 9;321(19):1333–1334. doi: 10.1056/NEJM198911093211910. [DOI] [PubMed] [Google Scholar]
  23. Hyams K. C., Osman N. M., Khaled E. M., Koraa A. A., Imam I. Z., el-Ghorab N. M., Dunn M. A., Woody J. N. Maternal-infant transmission of hepatitis B in Egypt. J Med Virol. 1988 Feb;24(2):191–197. doi: 10.1002/jmv.1890240208. [DOI] [PubMed] [Google Scholar]
  24. Jilg W., Schmidt M., Deinhardt F. Persistence of specific antibodies after hepatitis B vaccination. J Hepatol. 1988 Apr;6(2):201–207. doi: 10.1016/s0168-8278(88)80032-1. [DOI] [PubMed] [Google Scholar]
  25. Loke R. H., Murray-Lyon I. M., Balachandran T., Evans B. A. Screening for hepatitis B and vaccination of homosexual men. BMJ. 1989 Jan 28;298(6668):234–234. doi: 10.1136/bmj.298.6668.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Meuer S. C., Dumann H., Meyer zum Büschenfelde K. H., Köhler H. Low-dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination. Lancet. 1989 Jan 7;1(8628):15–18. doi: 10.1016/s0140-6736(89)91674-7. [DOI] [PubMed] [Google Scholar]
  27. Milich D. R., McNamara M. K., McLachlan A., Thornton G. B., Chisari F. V. Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region. Proc Natl Acad Sci U S A. 1985 Dec;82(23):8168–8172. doi: 10.1073/pnas.82.23.8168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Milich D. R., Thornton G. B., Neurath A. R., Kent S. B., Michel M. L., Tiollais P., Chisari F. V. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science. 1985 Jun 7;228(4704):1195–1199. doi: 10.1126/science.2408336. [DOI] [PubMed] [Google Scholar]
  29. Miller K. D., Gibbs R. D., Mulligan M. M., Nutman T. B., Francis D. P. Intradermal hepatitis B virus vaccine: immunogenicity and side-effects in adults. Lancet. 1983 Dec 24;2(8365-66):1454–1456. doi: 10.1016/s0140-6736(83)90800-0. [DOI] [PubMed] [Google Scholar]
  30. Mulley A. G., Silverstein M. D., Dienstag J. L. Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis. N Engl J Med. 1982 Sep 9;307(11):644–652. doi: 10.1056/NEJM198209093071103. [DOI] [PubMed] [Google Scholar]
  31. Piazza M., Da Villa G., Picciotto L., Abrescia N., Guadagnino V., Memoli A. M., Vegnente A., Iorio R., Cimmino L. Mass vaccination against hepatitis B in infants in Italy. Lancet. 1988 Nov 12;2(8620):1132–1132. doi: 10.1016/s0140-6736(88)90540-5. [DOI] [PubMed] [Google Scholar]
  32. Polakoff S. Acute viral hepatitis B, reported to the Public Health Laboratory service. J Infect. 1990 Mar;20(2):163–168. doi: 10.1016/0163-4453(90)93522-t. [DOI] [PubMed] [Google Scholar]
  33. Poovorawan Y., Sanpavat S., Pongpunlert W., Chumdermpadetsuk S., Sentrakul P., Safary A. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers. JAMA. 1989 Jun 9;261(22):3278–3281. [PubMed] [Google Scholar]
  34. Schoub B. D., Johnson S., McAnerney J. M., Blackburn N., Kew M. C., McCutcheon J. P., Carlier N. D. Integration of hepatitis B vaccination into rural African primary health care programmes. BMJ. 1991 Feb 9;302(6772):313–316. doi: 10.1136/bmj.302.6772.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Scolnick E. M., McLean A. A., West D. J., McAleer W. J., Miller W. J., Buynak E. B. Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA. JAMA. 1984 Jun 1;251(21):2812–2815. [PubMed] [Google Scholar]
  36. Stevens C. E., Alter H. J., Taylor P. E., Zang E. A., Harley E. J., Szmuness W. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med. 1984 Aug 23;311(8):496–501. doi: 10.1056/NEJM198408233110803. [DOI] [PubMed] [Google Scholar]
  37. Stevens C. E., Beasley R. P., Tsui J., Lee W. C. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975 Apr 10;292(15):771–774. doi: 10.1056/NEJM197504102921503. [DOI] [PubMed] [Google Scholar]
  38. Szmuness W., Stevens C. E., Harley E. J., Zang E. A., Oleszko W. R., William D. C., Sadovsky R., Morrison J. M., Kellner A. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980 Oct 9;303(15):833–841. doi: 10.1056/NEJM198010093031501. [DOI] [PubMed] [Google Scholar]
  39. Wainwright R. B., McMahon B. J., Bulkow L. R., Parkinson A. J., Harpster A. P. Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Seven-year results. Arch Intern Med. 1991 Aug;151(8):1634–1636. [PubMed] [Google Scholar]
  40. Whittle H. C., Bradley A. K., McLauchlan K., Ajdukiewicz A. B., Howard C. R., Zuckerman A. J., McGregor I. A. Hepatitis B virus infection in two Gambian villages. Lancet. 1983 May 28;1(8335):1203–1206. doi: 10.1016/s0140-6736(83)92477-7. [DOI] [PubMed] [Google Scholar]
  41. Whittle H. C., Inskip H., Hall A. J., Mendy M., Downes R., Hoare S. Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia. Lancet. 1991 Mar 30;337(8744):747–750. doi: 10.1016/0140-6736(91)91367-4. [DOI] [PubMed] [Google Scholar]
  42. Williams J. R., Flowerdew A. D. Uptake of immunisation against hepatitis B among surgeons in Wessex Regional Health Authority. BMJ. 1990 Jul 21;301(6744):154–154. doi: 10.1136/bmj.301.6744.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Wismans P. J., van Hattum J., Mudde G. C., Endeman H. J., Poel J., de Gast G. C. Is booster injection with hepatitis B vaccine necessary in healthy responders? A study of the immune response. J Hepatol. 1989 Mar;8(2):236–240. doi: 10.1016/0168-8278(89)90013-5. [DOI] [PubMed] [Google Scholar]
  44. Zuckerman A. J. Tomorrow's hepatitis B vaccines. Arie Zuckerman discusses hepatitis B vaccines of the future and the impact of AIDS on immunization. Vaccine. 1987 Sep;5(3):165–167. doi: 10.1016/0264-410x(87)90092-2. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES